Serial #79195139 Trademark
Serial Number: 79195139 • Registration: 5163668
Serial #79195139 is a trademark filed by
MERCK KGAA
on June 29, 2016. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Trademark Details
Filing Date
June 29, 2016
Registration Date
March 21, 2017
Published for Opposition
January 3, 2017
Cancellation Date
October 6, 2023
Goods & Services
Pharmaceutical preparations for use in the field of oncology
Filing History
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 20, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 28, 2024 INTS
INVALIDATION PROCESSED
Jun 27, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 14, 2024 INTR
CANCELLED SECTION 71
Oct 6, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 21, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 14, 2017 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Jun 27, 2017 FICS
FINAL DISPOSITION PROCESSED
Jun 27, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 21, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 21, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jan 3, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 14, 2016 NONP
REFUSAL PROCESSED BY IB
Dec 2, 2016 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2016 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 18, 2016 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2016 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 16, 2016 RFCS
REFUSAL PROCESSED BY MPU
Nov 16, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 15, 2016 RFCR
NON-FINAL ACTION WRITTEN
Nov 14, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 8, 2016 MAFR
ASSIGNED TO EXAMINER
Nov 4, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 3, 2016 REPR
